Katrin Milger

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial

Jürgen Behr, Antje Prasse, Michael Kreuter et al. · The Lancet Respiratory Medicine · 2021 · 490 citations · Full text

Antifibrotic Therapy, Advanced Lung Disease, Idiopathic Pulmonary Fibrosis +6

Inducible NOS Inhibition Reverses Tobacco-Smoke-Induced Emphysema and Pulmonary Hypertension in Mice

Michael Seimetz, Nirmal Parajuli, Alexandra Pichl et al. · Cell · 2011 · 340 citations · Full text

Asthma, Tobacco Control, Pulmonary Arterial Hypertension +9

COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension

Marius M. Hoeper, Christine Pausch, Karen M. Olsson et al. · European Respiratory Journal · 2021 · 309 citations · Full text

The Giessen Pulmonary Hypertension Registry: Survival in pulmonary hypertension subgroups

Henning Gall, Janine F. Felix, Franziska K. Schneck et al. · The Journal of Heart and Lung Transplantation · 2017 · 300 citations · Full text

Cellular uptake of fatty acids driven by the ER-localized acyl-CoA synthetase FATP4

Katrin Milger, Thomas Herrmann, Christiane Becker et al. · Journal of Cell Science · 2006 · 226 citations

Long-chain Fatty Acids, Biosynthesis, Engineering +14